David T. Curiel, M.D., Ph.D. heads the Gene Therapy Center (GTC) of the University of Alabama at Birmingham. Dr. Curiel graduated medical school at Emory University in 1982 where he also completed his internship and residency in Internal Medicine. Dr. Curiel's scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland, at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990. Dr. Curiel has been at the University of Alabama at Birmingham since 1993. He received his Ph.D. in 2002 from the University of Groningen, in the Netherlands.
In addition to his role as Director of the Gene Therapy Center, he is Director of the Division of Human Gene Therapy which is affiliated with the Departments of Medicine, Pathology, Surgery and Obstetrics and Gynecology at the University of Alabama at Birmingham, the holder of the Jeanne and Ann Griffin chair of women's cancer research.